The efficiency of cabergoline versus pyridoxine for lactation inhibition – a randomized controlled trial
Some mothers may seek lactation inhibition on personal, social, or medical grounds. The common drug used for lactation inhibition is cabergoline. Several adverse effects and contraindications are known for this drug. Its use is contraindicated for patients with hypertensive disorders and fibrotic, cardiac, or hepatic diseases. Pyridoxine (Vitamin B6) has also been used for this indication, with no significant adverse effects, following studies that demonstrated its efficacy.
Source: American Journal of Obstetrics and Gynecology - Category: OBGYN Authors: Adi DAYAN-SCHWARTZ, Enav YEFET, Manal MASSALHA, Sally HOSARI-MHAMEED, Chen REMER-GROSS, Eliran PASAND, Zohar NACHUM Tags: Original Research: Obstetrics Source Type: research